Table 7.

Effect of UPW-RMD and DOW-RMD on hepatosomatic and renalindex in male SD rat.

Groups	AST (U/L)	ALT (U/L)	Creatinine (mg/dL)	Uric acid (mg/dL)
NOR	113.4 ± 11.5 b	53.8 ± 3.8 ab	0.50 ± 0.00 c	3.1 ± 0.8 a
HF	111.3 ± 14.2 b	52.1 ± 3.9 ab	0.50 ± 0.00 c	4.0 ± 0.8 bc
UPW-R-1X	93.0 ± 10.5 ab	42.8 ± 5.7 b	0.44 ± 0.07 ab	3.6 ± 0.5 ab
DOW-R-1X	85.1 ± 11.0 a	38.6 ± 4.5 a	0.39 ± 0.04 a	3.0 ± 0.5 a
DOW-R-2X	88.8 ± 7.4 a	45.5 ± 2.6 ab	0.43 ± 0.07 ab	3.2 ± 0.3 a
MS	95.9 ± 42.1 ab	63.1 ± 53.1 b	0.44 ± 0.04 ab	4.4 ± 1.0 c
AK	89.3 ± 21.8 ab	51.9 ± 26.0 ab	0.45 ± 0.04 bc	4.5 ± 0.4 c

NOR, normal diet (3.34 kcal/g); HF, high-fat diet (4.17 kcal/g); UPW-R-1X, UPW-RMD powder (1×, 27.81 mg/day 100 g bw) and high-fat diet; DOW-R-1X, DOW-RMD powder (1×, 27.81 mg/day 100 g bw) and high-fat diet; DOW-R-2X, DOW-RMD powder (2×, 55.62 mg/day 100 g bw) and high-fat diet; and high-fat diet; MS, monascin powder (2×, 0.152 mg/day 100 g bw) and high-fat diet; AK, ankaflavin powder (2×, 0.162 mg/day 100 g bw) and high-fat diet. Data are presented as means ± SD (n = 8). Mean values within each column with different superscripts are significant difference (p < 0.05).